Vincerx Pharma Inc
NASDAQ:VINC

Watchlist Manager
Vincerx Pharma Inc Logo
Vincerx Pharma Inc
NASDAQ:VINC
Watchlist
Price: 0.6598 USD 4.73%
Market Cap: 3.5m USD

Vincerx Pharma Inc
Investor Relations

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California and currently employs 56 full-time employees. The company went IPO on 2020-03-10. The Company’s small molecule drug program includes VIP152, which is a highly selective, clinical-stage positive transcription elongation factor-beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. The firm's antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924 (targeting CXCR5), which are ADC compounds addressing known and novel oncology targets. The Company’s bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors.

Show more
Loading
VINC
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

No Earnings Calls Available

Management

Dr. Ahmed M. Hamdy M.D.
Co-Founder, Chairman & CEO
No Bio Available
Dr. Raquel E. Izumi Ph.D.
Co-Founder, President, COO, Secretary & Director
No Bio Available
Mr. Alexander A. Seelenberger M.B.A.
Chief Financial Officer
No Bio Available
Mr. Tom C. Thomas J.D.
Founder, General Counsel & Chief Legal Officer
No Bio Available
Dr. John C. Byrd M.D.
Founder & Chairman of Scientific Advisory Board
No Bio Available
Dr. Hans-Georg Lerchen Ph.D.
Chief Scientific Officer
No Bio Available
Ms. Gabriela Jairala
Vice President of Investor Relations & Corporate Communications and Chief of Staff
No Bio Available
Ms. Karen Quarford M.B.A.
Vice President of Quality Operations & Compliance
No Bio Available
Ms. Melissa Merrick SPHR
Senior Director of People & Culture and Head of Human Resource
No Bio Available
Dr. Beatrix Stelte-Ludwig Ph.D.
Executive Chief Development Officer
No Bio Available

Contacts

Address
CALIFORNIA
Palo Alto
260 Sheridan Avenue, Suite 400
Contacts
+16508006676.0
vincerx.com
sparklesyt

See Also

Summary
VINC intrinsic value, competitors valuation, and company profile.
DCF Valuation
VINC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VINC stock valuation using valuation multiples.
Wall Street Estimates
VINC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VINC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.